WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home COMPANY FACT SHEET About Us Corporate Responsibility Reimbursement Support and Patient Assistance Programs Leadership Board of Directors Executive Committee Our Work How We Operate Code of Conduct Compliance Privacy Transparency and Privacy Internet Privacy Policy Cookie Privacy Commitment Cross Border Policy Employment Privacy & Data Protection Diversity Employee Diversity Supplier Diversity Views and Positions Access and Affordability Access to Investigational Medicines Innovation Quality and Safety Sales and Marketing Responsible Public Policy and Advocacy Our History Our People Featured Stories Ticker MRK Name The company is known as Merck in the United States and Canada. Everywhere else, we are known as MSD. Merck & Co., Inc. is the legal name and is listed on the New York Stock Exchange under the symbol "MRK." Description Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world. Our core product categories include diabetes, cancer, vaccines and hospital acute care. We continue to focus our research on conditions that represent some of today’s most significant health challenges – like cancer, hepatitis C, cardio-metabolic disease, antibiotic-resistant infection and Alzheimer's disease, and we are on the front lines in the fight against emerging global pandemics, such as ebola. We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them. At Merck, we're applying our global reach, financial strength and scientific excellence to do more of what we're passionate about: improving health and improving lives. Employees Approximately 68,000 (as of March 31, 2016) Headquarters Kenilworth, New Jersey Businesses Pharmaceuticals Vaccines Animal Health 2015 Revenue $39.5 billion 2015 Revenues (By Geographic Region) United States $17.5 billion Europe, Middle East and Africa $10.7 billion Asia Pacific $ 3.8 billion Japan $ 2.7 billion Latin America $ 2.8 billion Other $ 2.0 billion 2015 R&D Expense $6.6 billion (excludes restructuring and merger related expenses) Products Merck is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. View the list of products marketed in the United States. Pipeline Merck has a robust pipeline, with a wide range of product candidates across each phase of development. View the pipeline. Senior Leadership Kenneth C. Frazier, chairman of the board, president and chief executive officer View the list of Executive Committee members. Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map